🗨️ “𝐼𝑡’𝑠 𝑎𝑏𝑜𝑢𝑡 𝑐𝑟𝑒𝑎𝑡𝑖𝑛𝑔 𝑎 𝑚𝑢𝑡𝑢𝑎𝑙𝑙𝑦 𝑏𝑒𝑛𝑒𝑓𝑖𝑐𝑖𝑎𝑙 𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛𝑠ℎ𝑖𝑝 𝑤𝑖𝑡ℎ 𝐾𝑜𝑟𝑒𝑎𝑛 𝑐𝑢𝑠𝑡𝑜𝑚𝑒𝑟𝑠. 𝑊𝑒 𝑤𝑖𝑙𝑙 𝑎𝑐𝑡𝑖𝑣𝑒𝑙𝑦 𝑠𝑢𝑝𝑝𝑜𝑟𝑡 𝐾𝑜𝑟𝑒𝑎𝑛 𝑐𝑜𝑚𝑝𝑎𝑛𝑖𝑒𝑠 𝑠𝑜 𝑡ℎ𝑎𝑡 𝑡ℎ𝑒𝑦 𝑐𝑎𝑛 𝑏𝑒 𝑎𝑐𝑡𝑖𝑣𝑒 𝑛𝑜𝑡 𝑜𝑛𝑙𝑦 𝑜𝑛 𝑡ℎ𝑒 𝐾𝑜𝑟𝑒𝑎𝑛 𝑚𝑎𝑟𝑘𝑒𝑡, 𝑏𝑢𝑡 𝑎𝑙𝑠𝑜 𝑜𝑛 𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑚𝑎𝑟𝑘𝑒𝑡𝑠.”
📎 For Korean speakers, read the full article here by clicking this link
HTL Biotechnology took part in IMCAS 2026, one of the leading international congresses dedicated to aesthetic medicine and dermatology. This major event was an opportunity to highlight the company’s strategy, innovations, and commitment to advancing regenerative medicine through high-performance biopolymers.
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.